Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor

Pediatrics

Volumn 105, Issue 2, 2000, Pages 392-397

  Calhoun, Darlene A ^a   Lunøe, Mathilde ^a   Du, Yan ^a   Hutson, Alan D ^a   Veerman, Mark ^a   Christensen, Robert D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Granulocyte colony stimulating factor; Neonates; Neutrophils; Pharmacokinetics

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; CLINICAL ARTICLE; DRUG DISPOSITION; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NEUTROPENIA; NEUTROPHIL; NEWBORN; OXYGEN SATURATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEPSIS; SHOCK; URINALYSIS;

EID: 0033950378     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.105.2.392     Document Type: Article

References (34)

1. Dale D. A randomized controlled phase III trial of recombinant human granulocyte colony stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood. 1993;81:2496-2502
2. Calhoun D, Christensen R. Kostmann syndrome in preterm neonates. Pediatrics. 1997;99:259-261
3. Gillio A. Cytokine treatment of inherited bone marrow failure syndromes. Blood. 1993;81:1669-1674
4. Welte K, Zeidler C, Reiter A, Riehm H. Effects of granulocyte colony-stimulating factor in children with severe neutropenia. Acta Haematol. 1994;25:155-162
5. Gilmore M, Stroncek D, Korones D. Treatment of alloimmune neonatal neutropenia with granulocyte colony-stimulating factor. J Pediatr. 1994; 125:948-951
6. Rodwell R, Gray P, Taylor K, Minchinton R. Granulocyte colony stimulating factor treatment for alloimmune neonatal neutropenia. Arch Dis Child Fetal Neonatal Ed. 1996;75:F57-F58
7. Kummerle-Deschner J, Scheel-Walter H, Speer C. G-CSF therapy in a neonate with alloimmune neutropenia. Z. Geburtshilfe Neonatol. 1997;201: 273-276
8. Bonilla M, Dale D, Zeidler C, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol. 1994;88:723-730
9. Juul S, Calhoun D, Christensen R. Evaluation of "idiopathic neutropenia" in very-low-birth-weight infants. Acta Paediatr Scand. 1998;87: 963-968
10. Kocherlakota P, La Gamma E. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged pre-eclampsia associated neutropenia. Pediatrics. 1998;102:1107-1114
11. Kocherlakota P, La Gamma E. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia. Pediatrics. 1997;100(1). URL: http:// www.pediatrics.org/cgi/content/full/100/1/e6
12. Murray J, McClain K, Wearden M. Using granulocyte colony-stimulating factor for neutropenia during neonatal sepsis. Arch Pediatr Adolesc Med. 1994;148:764-766
13. Russell A, Davies E, Ball S, Gordon Smith E. Granulocyte colony stimulating factor treatment for neonatal neutropenia. Arch Dis Child Fetal Neonatal Ed. 1995;72:F53-54
14. Drossou Agakidou V, Kanakoudi Tsakalidou F, Sarafidis K, et al. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta 2 integrin expression: results of a randomized controlled trial. Eur J Pediatr. 1998;157:583-588
15. Racine-Poon A, Smith AF. In: Berry DA, ed. Statistical Methodology in the Pharmaceutical Sciences. 1st ed. New York, NY: Dekker; 1990:139-162
16. Gibaldi M, Perrier D. In: Pharmacokinetics. 2nd ed. New York, NY; Dekker; 1982:445-449. Appendix D
17. Al-Mulla Z, Christensen R. Neutropenia in the neonate. Clin Perinatol. 1995;22:711-739
18. Bonilla M, Gillio A, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989;320:1574-1580
19. Gillan E, Christensen R, Suen Y, Van de ven C, Cairo M. A randomized, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood. 1994;84:1427-1433
20. Cairo M, Mauss D, Kommareddy S, Norris K, Van de ven C, Modanlou H. Prophylactic or simultaneous administration of recombinant human granulocyte colony-stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Pediatr Res. 1990;27:612-616
21. Cairo M, Plunkett J, Mauss D, Van de ven C. Seven day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B streptococcus sepsis. Blood. 1990;76:1788-1794
22. Schibler K, Osborne K, Leung L, Le T, Baker S, Thompson D. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics. 1998;102:6-13
23. Ericson S, Gao H, Gericke G, Lewis L. The role of polymorphonuclear neutrophils in clearance of granulocyte colony-stimulating factor in vivo and in vitro. Exp Hematol. 1997;13:1313-1325
24. Kuwabara T, Kobayashi S, Sugiyama Y. Pharmacokinetics and pharmacodynamics of a recombinant human granulocyte colony-stimulating factor. Drug Metab Rev. 1996;28:625-658
25. Sturgill M, Huhn R, Drachtman R. Pharmacokinetics of intravenous recombinant human granulocyte colony-stimulating factor in children receiving myelosupressive cancer chemotherapy:clearance increases in relation to absolute neutrophil count with repeated dosing. Am J Hematol. 1997;54:124-130
26. Watari K, Ozawa K, Takahashi S, et al. Pharmacokinetic studies of intravenous glycosylated recombinant human granulocyte colony-stimulating factor in various hematological disorders: inverse correlation between half-life and bone marrow myeloid cell pool. Int J Hematol. 1997;1:57-67
27. Fukunaga R, Seto Y, Mizushima S, Nagata S. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci USA. 1990;87:8702-8706
28. Larsen A, Davis T, Curtis B, Gimpel S, Sims J. Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains. J Exp Med. 1990;172:1559-1570
29. Nicola N, Peterson L, Hilton D, Metcalf D. Cellular processing of murine colon-stimulating factor (Multi-CSF, GM-CSF, and G-CSF) receptors by normal hemopoietic cells and cell lines. Growth Factors. 1988;1:41-49
30. Elbaz O, Budel LM, Hoogerbrugge H, et al. Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes. J Clin Invest. 1991;87:838-841
31. Atici A, Satar M, Cetiner S, Yaman N. Serum tumor necrosis factor-alpha in neonatal sepsis. Am J Perinatol. 1997;14:401-104
32. Berner R, Niemeyer CM, Leititis JU, et al. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8 and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res. 1998;44: 469-477
33. Tada M, Diserens A, Desbaillets I, de Tribolet N. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J Neurosurg. 1994;80:1063-1073
34. Calhoun D, Donnelly W, Du Y, Dame J, Li Y, Christensen R. Distribution of granulocyte colony-stimulating factor receptor (G-CSF-R) and G-CSF-Receptor messenger RNA expression in the human fetus. Pediatr Res. 1999;46:333-338